GlaxoSmithKline Contract Details



Defense contract under the Defense Logistics Agency awarded to GlaxoSmithKline on 6/6/2014.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.


The contract language is EXACTLY as it appears on the official U.S. DoD website (http://www.defense.gov/contracts/) unless otherwise noted.




Contractor: GlaxoSmithKline
Department: Defense Logistics Agency
Awarded: 6/6/2014


GlaxoSmithKline, Research Triangle Park, North Carolina, has been awarded a maximum $17,616,339 firm-fixed-price contract for flu vaccines. This contract was a competitive acquisition with four offers received. This is a one-year base contract with no option periods. Location of performance is North Carolina with a Sept. 30, 2015, performance completion date. Using military service is Army, Navy, Air Force, Marine Corps, and federal civilian agencies. Type of appropriation is fiscal 2014 through fiscal 2015 defense working capital funds. The contracting activity is the Defense Logistics Agency Troop Support, Philadelphia, Pennsylvania (SPE2DP-14-D-0005).


Total Contract Value: $17,616,339


View all contracts that include "GlaxoSmithKline" in the MiC database.